Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hippocampal Volume and Anxiety in Major Depressive Disorder
NCT04430556Unknown
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Jul 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sertraline in major depressive disorder (MDD) and anxiety disorder, sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Primary endpoint: Hamilton Anxiety Rating Scale at 8 weeks. Status: unknown.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NCT04430556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04430556.